INVENTORY OF SUPPLEMENTAL INFORMATION

SUPPLEMENTAL EXPERIMENTAL PROCEDURES Microarray gene expression analysis
Gene expression datasets were obtained from the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database under the accessions GSE16161, GSE13355, GSE6012 and GSE6710. Data was utilized in the processed form from its original study. A gene set comprising members of the Notch pathway was constructed using information from additional references provided in Supplemental Data and literature cited in main text. Probes mapping to these genes were identified on the Affymetrix HGU133A (GSE6710 and GSE6012, 84 probes - Table S1) and HGU133 Plus2 platforms (GSE13355 and GSE16161, 142 probes - Table S1 ).
Differential expression for genes within the Notch set was examined using a welch t-test, and the False Discovery Rate (Benjamini, 1995) was employed to control for multiple hypotheses, using a cutoff of 5.0% (Table S1 ). In each dataset we compared: atopic dermatitis vs. normal (GSE16161), atopic eczema vs. normal (GSE6012) or psoriasis vs normal (GSE13355 and GSE6710). Significantly differentially expressed genes were visualized using matrix2png (Pavlidis and Noble, 2003) , after collapsing probes to genes at their median value, and scaling the data to N(0,1). Samples in GSE16161 were subjected to hierarchical clustering (uncentered correlation and average linkage) for the complete Notch signaling gene set in Cluster 3.0 (Eisen et al., 1998) and the resulting dendogram was visualized using Java TreeView (Saldanha, 2004) . The following references were cited in addition to those listed in the main text: (Artavanis- Tsakonas et al., 1999; Ehebauer et al., 2006; Harada et al., 1999; Jeffries and Capobianco, 2000; Kopan, 2002; Kramer, 2000; Liu et al., 2003; Ohishi et al., 2000; Wu et al., 2002) .
Isolation and culture of primary keratinocytes
For calcium-induced differentiation and ligand-independent Notch activation, cells were cultured with 1mM CaCl 2 in calcium-free Eagles' MEM supplemented with 16% calcium-free (chelated) serum. For ligand-dependent Notch activation, cells were incubated with a fusion protein consisting of mouse Delta Like 4 and human-Fc at 1µg/ml cross-linked with 1µg/ml anti-human IgG1 (H+L, Pierce). Anti-human IgG1 alone was used as a control. For PMA treatments (Phorbol 12-myristate 13-acetate, P8139, Sigma), media was changed to serum-free, calcium-free eagles MEM. PMA was added at 10ng/ml. Pan AP-1 activity was inhibited by pre-treating keratinocytes with 20µM Tanshinone IIA (Enzo Life Sciences, TanIIA) 18 hours prior to PMA treatment.
TanIIA was maintained for the duration of PMA treatment. To measure EGFR suppression of IL-33 transcription, PMA was added at 50ng/ml for 3hr, soluble recombinant mouse EGF (sEGF) added at 100ng/ml and Erlotinib at 20µM in DMSO 1hr prior to PMA treatment. sEGF and Erlotinib were maintained for the duration of PMA treatment. For EDTA stimulation, cells were washed in Hanks Balanced Salt Solution (HBSS, without calcium) and EDTA added at 5mM for indicated timepoints. Following treatment, cells were allowed to recover for 1hr in calcium-free Eagles' MEM supplemented with 16% calcium-free (chelated) serum after which protein was harvested for immunoblotting. To measure gene expression changes in this experiment, cells were allowed to recover for 4hr after EDTA treatment after which RNA was harvested. Table S2 .
Culture and treatment of HaCaT cells and chromatin immunoprecipitation (ChIP)
Human
Flow cytometry
For splenocyte analysis, red blood cell lysis was performed using AFCS buffer prior to staining. Superficial axillary and brachial lymph nodes were denoted as skindraining lymph nodes (dLNs). Mesenteric lymph nodes (mLNs) were isolated as controls.
Bone marrow cells were obtained from one femur and tibia per mouse. For cytokine analysis, total dLN cells were left unstimulated in RPMI + 5% FBS and 10µg/ml Brefeldin A or stimulated with 100ng/ml PMA + 1µg/ml Ionomycin in presence of 10µg/ml Brefeldin A for 4-6hr. Cells were collected and stained with viability dye and surface markers, followed by fixation (BD Cytofix/Cyoperm kit) and finally cytokine staining. For analysis of skin macrophages, upper dorsal skin was shaved and depilated using Nair. The skin was washed with water and removed from the mouse. Dermal fat was scraped off using a scalpel. Tissues were then finely minced with scissors and digested with 0.14 U/ml Liberase Blendzyme 2 and 100 μg/ml DNase I (Roche) in 10ml plain RPMI per skin, while being stirred at 37°C for 20 min. Released cells were filtered through a 70-μm strainer. The tissue was washed with 10mL RPMI + DNase I. This was repeated 2 times, pooling all released cells. A final volume of 30ml containing filtered cells was centrifuged at 1200RPM (220g) for 10min, and cells were resuspended in 1ml FACS buffer. Cells were counted and viability measured using trypan blue. Cells were 
Immunoblotting and AP-1 binding assay
Keratinocytes were treated with 10ng/ml PMA for 3 hours. Protein was obtained from tail epidermis by mortar and pestle homogenization of frozen tissue. Protein from keratinocytes was obtained by washing cells with ice cold PBS followed by lysis in RIPA extraction buffer. 10 to 50 μg protein was loaded onto SDS-PAGE gels for immunoblotting. Nuclear lysate for AP-1 binding assays was obtained using standard protocols (Murthy et al., 2010) . AP-1 binding to target sequence (TRE oligonucleotide) was measured by using AP-1 family EZ-TFA Transcription Factor Assay (Millipore).
The AP-1 antibodies listed below were used instead of those provided in the kit. The following anti-mouse antibodies were used: anti-ADAM17 (Khokha lab), anti-active 
Stimulation of bone marrow and spleen cells to measure IL-12 production
Total spleen or bone marrow cells were obtained and red blood cells lysed using AFCS buffer. 5x106 cells were plated in RPMI + 5% FBS and left unstimulated or stimulated with 100ng/ml IFNγ for 2h followed by addition of 100ng/ml LPS for 22h.
Cell culture media was collected and analyzed for IL-12/23p40 or IL-12p70 by ELISA (eBioscience).
AP-1 luciferase assay and PMA treatment of mouse embryonic fibroblasts (MEFs)
MEFs were transduced with lentiviral AP-1 firefly luciferase and Renilla luciferase as a control 48 hours prior to treatment (Cignal AP1 reporter, SABiosciences).
Cells were treated with 10ng/ml PMA in serum-free DMEM for 18 hours. To inhibit cFos/AP-1, MEFs were pre-treated with 20µM T-5224 (kindly provided by Dr. Erwin Wagner) 3 hours prior to PMA treatment. T-5224 was maintained for the duration of PMA treatment. AP-1 activity was calculated as a ratio of AP-1 luciferase luminescence divided by constitutive Renilla luciferase luminescence and depicted as relative luminescence units (RLU).
RNA isolation and quantitative PCR (qPCR)
RNA was prepared from frozen dorsal epidermis or fresh keratinocytes using TRIzol reagent (Invitrogen) following standard protocols. cDNA was obtained using a first-strand cDNA synthesis protocol (Quanta). Gene expression was measured using SYBR Green reagent (Quanta) in a 7800HT real-time PCR system (Applied Biosciences). All gene expression levels were normalized to Actb (β-actin), and fold change was measured relative to control wild-type samples. qPCR of RNA was used as a negative control. The amount of each product was calculated using the 2 -Δ∆CT method.
Primer sequences are provided in Table S2 .
Histology & cytokine analysis
Dorsal skin was obtained and dissected longitudinally along dorsal midline and processed as in . The following stains were applied for immunohistochemical analysis:
Harris' hematoxylin and eosin, Toluidine B, anti-Ki67 ( were measured by standard ELISA following manufacturer's protocols.
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